TP53 and cancer: It is assumedthat under conditions of suppressed pyrimidine biosynthesis, the cytoprotectiveproperties of p53 (promoting the survival of normal cells with wild-type p53and death of cancer cells with inactivated p53) may be used for anti-tumortherapy employing the proper inhibitors [12].